跳至主要内容
临床试验/CTRI/2025/02/080200
CTRI/2025/02/080200尚未招募不适用

An Open Labelled Randomised Comparative Clinical Study To Evaluate The Efficacy Of Guduchiyadi Aasthapana Basti And Madhutailik Basti In Management Of Gambhir Vatarakta [Ankylosing Spondylitis]

Institute for Ayurved Studies and Research Shri krishana Ayush University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年3月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Quantitative improvement in the value of HLAB-27

研究概览

简要总结

Ankylosing Spondylitis is characterized by chronic inflammatory arthritis predominantly affecting the sacroiliac joints and spine which can progress to bony fusion of the spine(1). Chronic back pain and progressive spinal stiffness are the most common features of the disease. Symptoms are exacerbated by inactivity and relieved by rest. Ankylosing spondylitis cannot be directly correlated with any particular disease in Ayurveda. However, on the basis of symptoms of disease, it can be correlated with Gambhir Vatarakta. To assess the effect of Guduchyadi Aasthapana Basti and Madhutailik Basti in reduction of HLAB-27 value.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient who are Basti.
  • Individuals displaying the symptoms of Ankylosing Spondylitis will be chosen as patients, regardless of their caste, religion or occupation.
  • Individuals displaying the symptoms of Gambhir Vatarakta will be chosen as patients, regardless of their caste, religion or occupation.
  • Patient within age group of
  • 60 years.
  • HLA B-27 will be positive.
  • Patient who is willing and able to participate in the study.

排除标准

  • Patients aged below 18 years and more than 60 yrs.
  • Patient who is contraindicated for Basti.
  • Pregnant and lactating women.
  • Patient with chronic systematic illness (Cardiac Diseases, Cirrhosis of the Liver, Diabetes, Hypertension, Chronic Renal Disorder, Carcinoma, Endocrine Disorders).
  • Patient with Ano-rectal Diseases.

结局指标

主要结局

Quantitative improvement in the value of HLAB-27

时间窗: Ist- 0 Day. | IInd - After the completion of total 16 Basti.

次要结局

  • Improvement in subjective and objective parameters.(Improvement in ESR & CRP values.)

研究者

发起方
Institute for Ayurved Studies and Research Shri krishana Ayush University
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Shubhi Sharma

Institute for ayurved studies and research Shri Krishana Ayush University

研究点 (1)

Loading locations...

相似试验